|
HS Code |
356681 |
| Chemical Name | Imidazo[1,2-a]pyridine-6-carboxylic acid |
| Cas Number | 122964-19-8 |
| Molecular Formula | C8H6N2O2 |
| Molecular Weight | 162.15 |
| Appearance | Off-white to light yellow powder |
| Purity | Typically ≥ 98% |
| Melting Point | 213-217 °C |
| Solubility | Slightly soluble in water, soluble in DMSO and methanol |
| Inchi Key | HTWHRUMJPUULNZ-UHFFFAOYSA-N |
| Smiles | C1=CN2C=CN=CC2=C1C(=O)O |
| Storage Conditions | Store at 2-8°C, protect from light and moisture |
| Synonyms | 6-Carboxyimidazo[1,2-a]pyridine |
As an accredited IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 5-gram amber glass bottle with a secure screw cap, labeled with product name, purity, quantity, and safety information. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID ensures secure, bulk packaging for efficient international shipment. |
| Shipping | **IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID** is shipped in secure, chemical-resistant containers to prevent contamination and ensure safety. The product is packed according to standard hazardous materials protocols, with appropriate labeling and documentation. Temperature and handling requirements are followed as per relevant regulations for chemical substances. Shipping complies with both national and international guidelines. |
| Storage | IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from heat, moisture, and direct sunlight. Avoid storage near incompatible substances such as strong oxidizers. Keep the container clearly labeled, and follow standard laboratory safety and chemical hygiene practices during handling and storage. |
| Shelf Life | IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID typically has a shelf life of 2–3 years when stored cool, dry, and protected from light. |
|
Purity 98%: IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID with purity 98% is used in medicinal chemistry synthesis, where it enables high-yield production of targeted bioactive compounds. Melting point 235°C: IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID with a melting point of 235°C is employed in high-temperature reaction optimization, where it maintains structural integrity and consistency. Particle size <20 µm: IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID with particle size less than 20 µm is utilized in pharmaceutical formulations, where it enhances dissolution rates and bioavailability. Stability temperature up to 120°C: IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID with stability temperature up to 120°C is applied in industrial-scale chemical processes, where it ensures minimal thermal degradation and product reliability. LC-MS purity 99%: IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID with LC-MS purity of 99% is used in analytical reference standards, where it guarantees precise quantification in method validation. Molecular weight 175.16 g/mol: IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID at molecular weight 175.16 g/mol is incorporated in lead compound libraries, where it allows for accurate molecular modeling and SAR studies. |
Competitive IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years of working with heterocyclic building blocks have taught us the value of a robust scaffold like IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID. Our process begins with a close look at every detail, right down to reaction temperature profiles and purification steps. We prepare batches ranging from gram-scale for research groups up to multi-kilogram lots for pharmaceutical manufacturers, always monitoring for consistency with in-house HPLC, NMR, and mass spectrometry. Typical purity of our material exceeds 98 percent – anything less interrupts downstream transformations.
Our typical lot delivers as a pale off-white solid, melting between 240 and 243 degrees Celsius. Analysts in our team, used to the unique smell and characteristic solubility behavior, recognize it instantly. Solubility in DMSO, DMF, and basic water is reliable, which opens up ways to handle complex derivatizations straight from solution. Out of our own experience, we’ve found that maintaining tight control of residual solvents and trace metal content stems from batch dialogue with QC rather than just running external certificates. This approach avoids headaches in complex routes where even small impurities can cause side products, leading to repeated purification or loss of yield.
In our standard offering, moisture content rests below 0.5 percent, as determined by Karl Fischer titration. We pack the product in sealed glass or fluorinated bottles — humidity swings during shipping often affect compounds of this class, so our in-house packaging is designed to withstand that. Every container carries a COA tied to the actual batch, pulled directly from the same containers we ship, not from pilot run samples.
IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID finds its place in medicinal chemistry, especially where structure-activity relationships depend on rigid aromatic frameworks. Chemists see value in its capacity to serve as a starting point for further elaboration: the aromatic core, with nitrogen atoms poised for hydrogen bonding, serves as a launching platform for kinase inhibitor fragments and anti-infective motifs. We receive requests for custom analogs with halogen, alkyl, or methoxy substitutions — our experience in directed ortho-metalation and Suzuki cross-coupling chemistry comes directly from tuning batches for such demands.
In practice, our partners use the acid for direct coupling to amines, attaching peptide-like side chains, or activating it via NHS esters. The robust stability under standard coupling conditions stands out among other isomeric carboxylic acids. A biopharma client once shared that switching from a pyridine-3-carboxylic acid derivative to our imidazo-fused acid eliminated byproduct formation during scale-up, attributing it to less competitive decarboxylation pathways. This kind of direct feedback shapes our process tweaks — we heard the concern, evaluated the route, adopted more selective crystallization steps, and brought back a sample meeting tighter product specs.
Plenty of benzo-fused and pyridine-carboxylic acids graze on the market shelves. In working with IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID, the most insistent difference lies in its electronic arrangement, which reflects in reactivity at the 6-position. Unlike classic nicotinic or picolinic acid derivatives, this scaffold’s aromatic electron density is split more evenly across both rings, limiting side reactions and broadening the accessible range of functionalization steps. Impurities tend to cluster less persistently, and post-reaction workups recover cleaner products with fewer chromatographic runs.
This backbone handles strong acid or base washing with minimal degradation — chemists working with competing isomers tell us they struggle with hydrolysis and ring-opening under similar conditions. Our own batch records show less than 1 percent decomposition under 24 hours in 1M NaOH, a property not matched by most related fused heterocycles, based on comparative stress-testing we conduct for every batch. That stability translates to cost savings downstream; less time cleaning up in the lab, fewer runs lost to impurities, and more reliable analytical profiles.
Not every synthesis or application goes as planned. Early versions of our product sometimes presented light yellow coloration or low-melting impurities, traced back to incomplete cyclization in the precursor steps. Relying on our own troubleshooting, we adjusted the oxidant profile, shifted to higher-purity starting materials, and boosted post-synthesis acid washing protocols. Since then, repeat problems with pigment or melting range variation disappeared. We treat each batch as a data point; customer complaints about filtration characteristics triggered tweaks to crystallization cooling rates. The result? Chemists downstream rarely see clumping or poor dispersibility.
Shipping across regions brings hurdles too. In humid zones, we began adding an extra molecular sieve packet in each container after tracking a spike in NMR signals linked to hydrate formation. We build relationships with transportation partners to minimize warehouse exposure, even negotiating temperature and humidity monitoring for bulk deliveries. Many years and hundreds of grader feedback forms guide our logistics and packing methods today, not theory or generic advice.
Working directly with formulation teams, we hear about hurdles that don’t crop up in bench-scale research. Scale-up from milligram to kilogram brings new realities — filtration speeds, equipment fouling, and exotherm management become real limiting factors. In the case of IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID, we’ve offered technical support to help engineers refine their charge sequence for smoother powder slurries. Sometimes, a simple change in addition technique — dry transfer under nitrogen, or wet-milling as slurry — fixes persistent issues faster than switching suppliers.
Synthetic researchers often reach out looking for documentation on side-product profiles or real-time impurity development as they adapt the molecule for new targets. Our own archives contain not just the typical COA details, but impurity fingerprinting from dozens of parallel synthesis campaigns. We share these data sets for comparison, helping customers avoid blind spots in their own process development.
Producing heterocyclic acids on scale raises questions about waste, solvents, energy, and impact on the local environment. Over time, we developed solvent recovery cycles for our main steps, reducing both waste and operating costs. Recycling DMF, acetonitrile, and water where possible minimized disposal volumes. Our distillation team observes purity in recovered solvents, relying on analytical confirmation before re-use in subsequent syntheses. Reducing the use of halogenated chemicals became possible with more selective oxidants and milder purification.
Process engineers redirected some mixed acid waste into neutralization and safe discharge, working closely with environmental analysts. Participation in local waste management initiatives followed, ensuring community safety and compliance with updated industrial regulations. By documenting every update in process logs and CO2 emission records, we keep a factual timeline for internal review, sharing the key findings with collaborators. This record-keeping tracks progress in sustainability, not just in output.
With every run involving IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID, the practical side of worker safety stands front and center. Operators rely on enclosed reactors for charging strong acids and managing heat releases. Our site safety team runs regular training for handling powdered materials, as respiratory irritation risk stands higher than with most non-aromatic carboxylic acids. Fume hoods and localized exhaust systems stay in active use, with equipment checks forming part of every shift report.
Direct involvement with regulatory audits makes us conscious of risk. We maintain accurate batch records, register all substances in site chemical inventories, and keep exposure scenarios up to date. Responding to feedback from previous audits, we swapped to improved PPE and reviewed emergency protocols based on real-world drills, not hypothetical hazards.
Having produced IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID for years meant listening as much as synthesizing. Feedback from medicinal chemists, process engineers, QA inspectors, and regulatory managers shaped every version of our product and service. We avoid offering off-the-shelf advice; instead, dialogue with users builds the knowledge required to avoid pitfalls and make better choices. Repeat orders and ongoing research collaborations stand as proof of the relationship-focused way we work.
In an industry dense with quick-fix suppliers and resellers, controlling every step — from synthetic route development to packaging and after-sales support — gives us confidence in each container shipped. Every day, we see the impact those details have on project timelines, cost, and even key discoveries in the labs of our partners.
Scientific progress does not stand still. New therapeutic targets keep appearing, and medicinal chemistry seeks out frameworks able to hold up under challenging downstream chemistry. Our in-house team keeps an eye out for subtle process innovations, exploring greener methods, tighter analytics, and advanced impurity tracking. Regular review meetings bring production chemists and analytical scientists together to discuss new issues, shared wins, and opportunities for smarter batch planning.
The story of IMIDAZO[1,2-A]PYRIDINE-6-CARBOXYLIC ACID in our facility—treated not as a commodity but as a valuable tool—underlines the commitment to learning and improvement shaped by hands-on reality. Lessons learned from lab to plant, and from desk to loading dock, drive both our chemical know-how and our commitment to those who trust us with their innovations.